![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, February 08, 2018 3:38:41 PM
Most people suffering from psoriasis wouldn't bother asking their doctor for a prescription for a cream if they could buy a cheaper version almost anywhere else. The particular formula may not matter to most.
All I'm saying is, this company is in danger of being too slow to market. It's ridiculous that their "safety" study hasn't been announced after a year. I know they don't control it ... but how long then for an actual efficacy study ??
And as for the tablet, I've seen many other American companies bragging about their different approaches to ingestion -gum, water dissolving, infusion, etc. Competition for new methods of ingestion is intense already.
OWCP's delay gives the MMs and their tools like i-glo plenty to write about... further dragging their stock price down, AND that low price may prevent them from cheaply financing operations by the end of the year, and they're going to need $$.
I'm not selling yet... but there are many opportunities elsewhere.
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM